Phosphoinositide 3-kinase in T cell activation and survival

Area of Science:

• Immunology
• Cell Signaling
• Molecular Biology

Background:

• Phosphoinositide 3-kinases (PI3Ks) are key regulators of cellular processes including growth, proliferation, survival, differentiation, and metabolism.
• In T cells, PI3Ks are activated by various receptors such as the T cell receptor (TcR), co-stimulatory receptors, cytokine receptors, and chemokine receptors.

Purpose of the Study:

• To investigate the specific roles of PI3Ks in T cell receptor (TcR) and CD28 signaling pathways.
• To elucidate how PI3K activation by different receptors influences T cell proliferation and survival.

Main Methods:

• Utilized an inactivating mutation in the leukocyte-specific PI3K isoform, p110delta.
• Analyzed TcR-dependent proliferation under conditions of blocked or non-required CD28 co-stimulation.
• Assessed the impact of PI3K recruitment and activation by CD28 on Bcl-X(L) expression and T cell survival.

Main Results:

• Impaired TcR-dependent proliferation was observed with the p110delta mutation when CD28 co-stimulation was blocked or not required.
• CD28-mediated PI3K activation promotes T cell survival through increased Bcl-X(L) expression.
• CD28 signaling activates additional pathways regulating proliferation and interleukin-2 production independently of PI3K.

Conclusions:

• PI3K plays a role in both TcR and CD28 signaling pathways within T cells.
• Each receptor (TcR and CD28) may utilize distinct subsets of PI3K-controlled signaling pathways.
• This suggests a complex, context-dependent role for PI3K in T cell activation and function.